EZ-editor™ platform, large-scale cell resources, and standardised workflows support faster and more reliable knockout ...
Curia, a leading contract research, development and manufacturing organization (CDMO), today announced progress on the expansion at its Glasgow, UK sterile drug product facility as well as ...
Host Cell Line Selection: The first critical step is selecting the appropriate host cell line. This decision is based on factors such as growth characteristics, genetic stability, and productivity, ...
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a cell line development partnership with Score Pharma, Inc., a biopharmaceutical company ...
In intensified bioprocessing, the engineered CHO host supports higher titers and long culture duration in continuous ...
Think about your favorite medicine. Maybe it is a vaccine or a powerful antibody. Have you ever wondered how it is made? It does not come from a chemical plant. It often comes from living cells.
Advances in cell line engineering and microfluidic technologies offer substantial opportunities to shorten timelines in cell line development (CLD). However, as with any innovation, optimizing these ...
Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab, ...
Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...
SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...
Successful commercialization of a biopharmaceutical product is dependent upon an effective, high-quality cell-line development process. While high-throughput analytical instruments often take center ...
DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (SCPX) (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results